199 related articles for article (PubMed ID: 32374488)
1. Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.
Pollack SM; Somaiah N; Araujo DM; Druta M; Van Tine BA; Burgess MA; Chawla SP; Seetharam M; Okuno SH; Bohac C; Chen M; Yurasov S; Attia S
Cancer Med; 2020 Jul; 9(13):4593-4602. PubMed ID: 32374488
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.
Takahashi M; Takahashi S; Araki N; Sugiura H; Ueda T; Yonemoto T; Morioka H; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Shimura M; Kawai A
Oncologist; 2017 Aug; 22(8):979-988. PubMed ID: 28526720
[TBL] [Abstract][Full Text] [Related]
3. Synovial Sarcoma of the Hand and Foot: An Institutional Review.
Patel RR; Lupo PJ; Bishop AJ; Lin PP; Delclos GL; Lazar AJ; Benjamin RS; Araujo DM
Am J Clin Oncol; 2021 Jul; 44(7):361-368. PubMed ID: 33927134
[TBL] [Abstract][Full Text] [Related]
4. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
D'Angelo SP; Araujo DM; Abdul Razak AR; Agulnik M; Attia S; Blay JY; Carrasco Garcia I; Charlson JA; Choy E; Demetri GD; Druta M; Forcade E; Ganjoo KN; Glod J; Keedy VL; Le Cesne A; Liebner DA; Moreno V; Pollack SM; Schuetze SM; Schwartz GK; Strauss SJ; Tap WD; Thistlethwaite F; Valverde Morales CM; Wagner MJ; Wilky BA; McAlpine C; Hudson L; Navenot JM; Wang T; Bai J; Rafail S; Wang R; Sun A; Fernandes L; Van Winkle E; Elefant E; Lunt C; Norry E; Williams D; Biswas S; Van Tine BA
Lancet; 2024 Apr; 403(10435):1460-1471. PubMed ID: 38554725
[TBL] [Abstract][Full Text] [Related]
5. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
[TBL] [Abstract][Full Text] [Related]
6. The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.
Pollack SM
Expert Rev Vaccines; 2018 Feb; 17(2):107-114. PubMed ID: 29280411
[TBL] [Abstract][Full Text] [Related]
7. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group.
Cassier PA; Lefranc A; Amela EY; Chevreau C; Bui BN; Lecesne A; Ray-Coquard I; Chabaud S; Penel N; Berge Y; Dômont J; Italiano A; Duffaud F; Cadore AC; Polivka V; Blay JY
Br J Cancer; 2013 Aug; 109(4):909-14. PubMed ID: 23922114
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG).
Moreau-Bachelard C; Campion L; Toulmonde M; Le Cesne A; Brahmi M; Italiano A; Mir O; Piperno-Neumann S; Laurence V; Firmin N; Penel N; Duffaud F; Chevreau C; Bertucci F; Narciso B; Dubray-Longeras P; Delcambre C; Saada-Bouzid E; Boudou-Rouquette P; Soulie P; Perrin C; Blay JY; Bompas E
ESMO Open; 2022 Apr; 7(2):100402. PubMed ID: 35202953
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.
Gupta S; Gouw L; Wright J; Chawla S; Pitt D; Wade M; Boucher K; Sharma S
Invest New Drugs; 2016 Apr; 34(2):243-52. PubMed ID: 26897615
[TBL] [Abstract][Full Text] [Related]
11. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.
Zhang S; Kohli K; Black RG; Yao L; Spadinger SM; He Q; Pillarisetty VG; Cranmer LD; Van Tine BA; Yee C; Pierce RH; Riddell SR; Jones RL; Pollack SM
Cancer Immunol Res; 2019 Aug; 7(8):1237-1243. PubMed ID: 31171504
[TBL] [Abstract][Full Text] [Related]
12. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
Gounder MM; Merriam P; Ratan R; Patel SR; Chugh R; Villalobos VM; Thornton M; Van Tine BA; Abdelhamid AH; Whalen J; Yang J; Rajarethinam A; Duh MS; Bobbili PJ; Huynh L; Totev TI; Lax AK; Agarwal S; Demetri GD
Cancer; 2021 Apr; 127(8):1311-1317. PubMed ID: 33296083
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience.
Ates O; Aksoy S; Yeter H; Sunar V; Kertmen N; Dizdar O; Turker A; Kars A
Indian J Cancer; 2017; 54(1):321-325. PubMed ID: 29199714
[TBL] [Abstract][Full Text] [Related]
14. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature.
Andrassy RJ; Okcu MF; Despa S; Raney RB
J Am Coll Surg; 2001 Mar; 192(3):305-13. PubMed ID: 11245372
[TBL] [Abstract][Full Text] [Related]
15. Myxoid Liposarcomas: Systemic Treatment Options.
Nassif EF; Keung EZ; Thirasastr P; Somaiah N
Curr Treat Options Oncol; 2023 Apr; 24(4):274-291. PubMed ID: 36853469
[TBL] [Abstract][Full Text] [Related]
16. Treatment at relapse for synovial sarcoma of children and adolescents: A multi-institutional European retrospective analysis.
Ferrari A; Orbach D; Bergamaschi L; Schoot RA; van Noesel MM; Di Carlo D; Bisogno G; Alaggio R; Milano GM; Chiaravalli S; Fuccillo F; Laurence V; Corradini N; Gasparini P; Vennarini S; Pasquali S; Casanova M
Pediatr Blood Cancer; 2024 Jul; 71(7):e31038. PubMed ID: 38679840
[TBL] [Abstract][Full Text] [Related]
17. New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas.
Kantidakis G; Litière S; Neven A; Vinches M; Judson I; Blay JY; Wardelmann E; Stacchiotti S; D'Ambrosio L; Marréaud S; van der Graaf WTA; Kasper B; Fiocco M; Gelderblom H
Eur J Cancer; 2022 Oct; 174():261-276. PubMed ID: 36116829
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.
Salah S; Yaser S; Salem A; Al Mousa A; Abu Sheikha A; Sultan I
Med Oncol; 2013; 30(3):639. PubMed ID: 23780657
[TBL] [Abstract][Full Text] [Related]
19. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma.
Smith TA; Easley KA; Goldblum JR
Am J Surg Pathol; 1996 Feb; 20(2):171-80. PubMed ID: 8554106
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of liposarcoma subtypes to chemotherapy.
Jones RL; Fisher C; Al-Muderis O; Judson IR
Eur J Cancer; 2005 Dec; 41(18):2853-60. PubMed ID: 16289617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
